Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Research progress on the antitumor effects of astragaloside IV
Ruixi Zhou, Tiankang Guo, Junliang Li
European Journal of Pharmacology (2022) Vol. 938, pp. 175449-175449
Closed Access | Times Cited: 19

Showing 19 citing articles:

Oxidative stress: Roles in skeletal muscle atrophy
Han Zhang, Guangdong Qi, Kexin Wang, et al.
Biochemical Pharmacology (2023) Vol. 214, pp. 115664-115664
Closed Access | Times Cited: 95
Pharmacological Effects of Astragaloside IV: A Review
Yutong Liang, Biqiong Chen, Di Liang, et al.
Molecules (2023) Vol. 28, Iss. 16, pp. 6118-6118
Open Access | Times Cited: 46
Astragaloside/PVP/PLA nanofiber functional dressing prepared by coaxial electrostatic spinning technology for promoting diabetic wound healing
H. Wang, Lihong V. Wang, Zemei Liu, et al.
European Polymer Journal (2024) Vol. 210, pp. 112950-112950
Closed Access | Times Cited: 12
Integrated analysis of metabolomic and transcriptomic profiling reveals the effect of Buyang Huanwu decoction on Parkinson's disease in mice
Jianran Hu, Ping Li, Hongyan Han, et al.
Phytomedicine (2023) Vol. 114, pp. 154755-154755
Closed Access | Times Cited: 14
Oxidative Stress Regulates the Pathogenesis of Sarcopenia and Its Research Progress on Targeted Intervention of Chinese and Western Drugs
继婵 韦
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 1341-1349
Closed Access
The mechanism of astragaloside IV improving the regulation of miRNA-21 gene in allergic rhinitis in rat model
Xin Huang, Hui Liu, Tong Liu, et al.
Revue française d'allergologie (2025) Vol. 65, Iss. 3, pp. 104198-104198
Closed Access
Erlotinib-Conjugated O-Phenylenediamine Derived Fluorescent Carbon Nanodots (OPD@CD) Platform for Targeting Breast Cancer (MCF-7) Cells
Ali Ibrahim Shkhair, Anju S. Madanan, Susan Varghese, et al.
Journal of Fluorescence (2025)
Closed Access
Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV
Zehui Xu, Houle Zhou, Yihan Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115752-115752
Open Access | Times Cited: 9
Combination Nanodrug Delivery Systems Facilitate the Syncretism of Chemotherapy with Immunotherapy to Promote Cancer Treatment
Zishuo Guo, Haocheng Zheng, Tieshan Wang, et al.
Small (2024)
Closed Access | Times Cited: 3
Natural polysaccharides exert anti-tumor effects as dendritic cell immune enhancers
Hongtai Xiong, Xinpu Han, Liu Cai, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Exploring the role of NLRP3 inflammasome in diabetic nephropathy and the advancements in herbal therapeutics
Jiangyuan Jin, Mianzhi Zhang
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
Astragaloside IV attenuates sunitinib-associated cardiotoxicity by inhibiting COUP-TFII
Wanting Qin, Shaoling Li, Ziji Cheng, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24779-e24779
Open Access | Times Cited: 2
SP94 engineered erythrocyte membrane enhanced the targeted delivery of biomimetic nanosuspension with IDO immunotherapy and chemotherapy in liver cancer
Faisal Raza, Liangdi Jiang, Steven S.-L. Zhang, et al.
Chemical Engineering Journal (2024) Vol. 491, pp. 151709-151709
Closed Access | Times Cited: 2
Effects of Tongluo Jiedu prescription on immune function and oxidative stress in patients with oral cancer
Yue Yin, Yuan Yao, Yijie Li, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 17, pp. 3045-3052
Open Access | Times Cited: 2
Astragaloside Ⅳ mediates the effect and mechanism of KPNB1 on biological behavior and tumor growth in prostate cancer
Quan Ma, Xiaojun Lu, Wei Tian, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33904-e33904
Open Access | Times Cited: 1
Spatiotemporal delivery of multiple components of rhubarb-astragalus formula for the sysnergistic treatment of renal fibrosis
Qibin Zhang, Xiaofeng Ye, Lin Zhu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Potential antidepressant effects of a dietary supplement from Huáng qí and its complex in aged senescence-accelerated mouse prone-8 mice
Ming-Yu Chou, Yueching Wong, Shih-Yi Wang, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 3
New insight into the molecular mechanism of TCM Bufei Huoxue formula for chronic obstructive pulmonary disease based on network pharmacology and experimental verification
Yuanying Zhu, Shengyuan Hao, Yan Wu, et al.
Journal of Pharmacy and Pharmacology (2024) Vol. 76, Iss. 10, pp. 1340-1351
Closed Access
Protective Effect of Astragaloside IV against Cadmium-Induced Damage on Mouse Renal Podocytes (MPC5)
Pin Gong, Yue Shan, Fuxiong Shi, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 4897-4897
Open Access
Page 1

Scroll to top